| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02721875 2015-004490-32 Details | 2018-08-09 Interventional | 1 | 1 | Azacitidine Myelodysplastic… Preleukemia Syndrome | - Trial was prematurely discontinued and only one patient was treated. So it was not possible to draw any conclusion about volasertib monotherapy/with azacitidine, in patients with Myelodysplastic syndrome after Hypomethylating agent treatment failure | |||
| NCT01923311 2013-001969-16 Details | 2018-08-09 Interventional | 2/3 | 31 | Elvitegravir Acquired Immuno… HIV Infections Immunologic Def… Acquired Immune… | - - | |||
| NCT00012298 NCT01646879 Details | 2018-08-09 Interventional | 1/2 | 81 | Antibodies, Mon… Oprelvekin Rituximab Leukemia, Lymph… Lymphoma Lymphoma, B-Cel… Lymphoma, B-Cel… Lymphoma, Folli… Lymphoma, Non-H… Recurrence Waldenstrom Mac… Extranodal Marg… Nodal Marginal … Recurrent Grade… Recurrent Grade… Recurrent Grade… Recurrent Margi… Recurrent Small… Splenic Margina… Waldenström Ma… | Trial completed prematurely. - | |||
| NCT02585765 Details | 2018-08-08 Interventional | 2 | 0 | Pioglitazone Pressure Ulcer Spinal Cord Inj… Ulcer Pressure Ulcers Spinal Cord Inj… | an alternate plan of investigation was developed. - | |||
| NCT01636960 Details | 2018-08-08 Interventional | 1 | [1 Refs] | 9 | Peginterferon a… Melanoma Malignant Melan… | The study was terminated after 118 weeks from the study start, during the maintenance phase,
due to regulatory approval in Japan. The study was terminated after 118 weeks from the study start, during the maintenance phase, due to regulatory approval in Japan. | ||
| NCT02734940 Details | 2018-08-07 Interventional | 4 | 3 | Dexmedetomidine Fentanyl Ketamine Lidocaine Morphine Heart Diseases | Unable to find participants who met inclusion/exclusion criteria - | |||
| NCT02011126 Details | 2018-08-07 Interventional | 2 | 0 | Imetelstat Motesanib dipho… Hepatoblastoma Neuroblastoma Neuroectodermal… Neuroectodermal… Neuroectodermal… Osteosarcoma Recurrence Rhabdomyosarcom… Rhabdomyosarcom… Sarcoma, Ewing Previously Trea… Recurrent Child… Recurrent Child… Recurrent Ewing… Recurrent Neuro… Recurrent Osteo… | IND no longer available. - | |||
| NCT01795976 Details | 2018-08-07 Interventional | 2 | 2 | Cyclophosphamid… Fludarabine Interleukin-2 Oesophageal Can… | Withdrawal of funding - | |||
| NCT00899678 2014-004381-24 Details | 2018-08-07 Interventional | 2 | 99 | Certolizumab Pe… Crohn Disease Crohn's Disease | higher than projected discontinuation rate during Maintenance Phase - | |||
| NCT00728585 Details | 2018-08-07 Interventional | 2 | 0 | Mitogens Mucositis Neoplasms Stomatitis Gastrointestina… Malignant Neopl… | Withdrawn - | |||
| NCT00278564 Details | 2018-08-06 Interventional | 1 | 7 | Cyclophosphamid… Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Rituximab Muscular Diseas… Myositis MYOPATHY | high relapse rate Early termination leading to small numbers of subjects analyzed | |||
| NCT03465345 Details | 2018-08-03 Interventional | 1 | 0 | Metformin Proanthocyanidi… Procyanidin Prostatic Neopl… Prostate Cancer | Study was stopped to pursue a new treatment plan with a new study. - | |||
| NCT03196401 Details | 2018-08-03 Interventional | 1 | 0 | Durvalumab Plasmacytoma Solitary Bone P… | FDA recommendation - | |||
| NCT02363946 2015-001147-36 Details | 2018-08-03 Interventional | 1 | 65 | Diphenhydramine Promethazine Alpha 1-Antitry… Alpha-1 Antitry… | Company decision to terminate the trial - | |||
| NCT01445392 NCT00575770 Details | 2018-08-03 Interventional | 1 | 24 | Antibodies, Mon… Pemetrexed Mesothelioma Mesothelioma, M… | - - | |||
| NCT02846766 Details | 2018-08-02 Interventional | 2 | 0 | Lenvatinib Cancer | Unable to execute a contract agreement with the drug manufacturer. - | |||
| NCT01755520 2012-003630-16 Details | 2018-08-02 Interventional | 3 | 1893 | Aspirin Ticagrelor Acute Coronary … Angina, Stable Coronary Artery… Stable Angina | DSMB Interim Analyses - | |||
| NCT00200382 Details | 2018-08-02 Interventional | 2 | - | Bortezomib Carcinoma, Non-… Lung Neoplasms Non-small Cell … | The study did not achieve the statistical success to continue. - | |||
| NCT03370159 Details | 2018-08-01 Interventional | 1/2 | 0 | Docetaxel Thioctic Acid Carcinoma, Non-… Lung Neoplasms Stage IIIB Non-… Stage IV Non-Sm… | Sponsor decided not to move forward - | |||
| NCT03297463 Details | 2018-08-01 Interventional | 1/2 | 0 | Interleukin-2 Ipilimumab Brain Neoplasms Melanoma Neoplasm Metast… Brain Metastase… Hepatic Metasta… Metastatic Mela… Pulmonary Metas… | Replaced by another study. - |